Pleco Therapeutics Announces Expansion with the Incorporation of a U.S. Subsidiary and the Appointment of Michael Stalhamer as President

/PRNewswire/ -- Pleco Therapeutics BV, a specialty biopharmaceutical company developing novel treatments designed to detoxify the cancer promoting cellular...

Related Keywords

New York ,United States ,Rutgers University ,New Jersey ,India ,Netherlands ,Delaware ,Newark ,Nijmegen ,Gelderland ,New Jersey Institute Of Technology ,Michael Stalhamer ,Ivo Timmermans ,Glaxosmithkline ,Linkedin ,Heritage Pharmaceuticals ,Twitter ,College Of Engineering ,Regulatory Affairs ,Jersey Institute Of Technology ,Pleco Therapeutics United States Inc ,Vp Regulatory Affairs Product Development ,Novartis ,Vp Product Development ,Amylin Pharmaceuticals ,Pleco Therapeutics United States ,Vice President ,Product Development ,Acute Myeloid Leukaemia ,Artes Medical ,Chemical Engineering ,New Jersey Institute ,Chief Executive Officer ,Pleco Therapeutics ,